Dynamic quotes: Off
|
ETFs with ESRX as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 11.82% | iShares Dow Jones U.S. Health Care Providers Index (IHF) | +10.72 (14.70%) |
| 5.17% | Market Vectors Wide Moat ETF (MOAT) | +2.26 (11.00%) |
| 2.86% | iShares Dow Jones U.S. Health Care Index Fund (IYH) | +4.55 (5.64%) |
| 2.77% | Select Sector SPDR Fund - Health Care (XLV) | +6.24 (14.75%) |
| 2.39% | Vanguard Health Care ETF (VHT) | +11.40 (14.95%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Industry Overview Prescription drugs play a significant role in healthcare today and constitute the first line of treatment for many medical conditions. For millions of people, prescription drugs provide the hope of improved health and quality of life. Total medical costs for employers continue to outpace the rate of overall inflation. National health expenditures as a percentage of Gross Domestic Product are expected to increase to 19.6% in 2021 from an estimated 17.9% in 2012 according to the Centers for Medicare & Medicaid Services (“CMS”). In response to cost pressures being exerted on health benefit providers such as managed care organizations, health insurers, employers and unions, pharmacy benefit management (“PBM”) companies work to develop innovative strategies designed to keep medications affordable. ... More ...
Analyst Info |
|
| Annual EPS Est: | $3.74 |
| Quarterly EPS Est: | 1.1 |
| PEG Ratio: | .98 |
|
Mean Recommendation: View Summary / View All |
1.5 |
Data is provided by Zacks Investment Research
